Article Versions Notes

Roßkopf S, Eichholz KM, Winterberg D, Diemer KJ, Lutz S, Münnich IA, Klausz K, Rösner T, Valerius T, Schewe DM, et al. Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering. Antibodies. 2020; 9(4):63. https://doi.org/10.3390/antib9040063

Roßkopf, Sophia, Klara Marie Eichholz, Dorothee Winterberg, Katarina Julia Diemer, Sebastian Lutz, Ira Alexandra Münnich, Katja Klausz, Thies Rösner, Thomas Valerius, Denis Martin Schewe, and et al. 2020. "Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering" Antibodies 9, no. 4: 63. https://doi.org/10.3390/antib9040063

Roßkopf, S., Eichholz, K. M., Winterberg, D., Diemer, K. J., Lutz, S., Münnich, I. A., Klausz, K., Rösner, T., Valerius, T., Schewe, D. M., Humpe, A., Gramatzki, M., Peipp, M., & Kellner, C. (2020). Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering. Antibodies, 9(4), 63. https://doi.org/10.3390/antib9040063